Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the fourth quarter and full year ended December 31, 2024, and provided ...

Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $450 from $433 and keeps a Sector Perform rating on the shares. The company had a strong Q4, with revenue beating ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.

As of 12:02:09 PM EST. Market Open.

After hours: 7:59:01 p.m. EST ...

After hours: 7:52:17 p.m. EST ...

After hours: 7:47:10 pm GMT-5 ...

Graham Aviation Sales is offering a selection of Bell 206LR helicopters for sale that are not currently on the market. These helicopters are registered for commercial use and have been maintained by a ...